» Articles » PMID: 32190149

Identification of Key Pathways and Genes in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2020 Mar 20
PMID 32190149
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Nonalcoholic fatty liver disease (NAFLD) is one of the most common types of liver disease in the world. However, the molecular mechanisms regulating the development of NAFLD have remained unclear.

Material And Methods: In the present study, we analyzed two public datasets (GSE48452 and GSE89632) to identify differentially expressed mRNAs in the progression of NAFLD. Next, we performed bioinformatics analysis to explore key pathways underlying NAFLD development.

Results: Gene Ontology (GO) analysis showed that differentially expressed genes (DEGs) were mainly involved in regulating a series of metabolism-related pathways (including proteolysis and lipid metabolism), cell proliferation and adhesion, the inflammatory response, and the immune response. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that DEGs in NAFLD were mainly enriched in the insulin signaling pathway, peroxisome proliferator-activated receptor (PPAR) signaling pathway, and p53 signaling pathway. We also constructed protein-protein interaction (PPI) networks for these DEGs. Interestingly, we observed that key hub nodes in PPI networks were also associated with the progression of hepatocellular carcinoma (HCC).

Conclusions: Taken together, our analysis revealed that a series of pathways, such as metabolism and PPAR signaling pathways, were involved in NAFLD development. Moreover, we observed that many DEGs in NAFLD were also dysregulated in HCC. Although further validation is still needed, we believe this study could provide useful information to explore the potential candidate biomarkers for diagnosis, prognosis, and drug targets of NAFLD.

Citing Articles

Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.

Yu R, Huang Y, Hu X, Chen J Heliyon. 2024; 10(14):e32783.

PMID: 39108890 PMC: 11301246. DOI: 10.1016/j.heliyon.2024.e32783.


Kaempferol Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis (NASH) by Suppressing Neutrophil-Mediated NLRP3-ASC/TMS1-Caspase 3 Signaling.

Yang H, Li D, Gao G Molecules. 2024; 29(11).

PMID: 38893506 PMC: 11173805. DOI: 10.3390/molecules29112630.


Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension.

Petrenko O, Konigshofer P, Brusilovskaya K, Hofer B, Bareiner K, Simbrunner B iScience. 2024; 27(3):109301.

PMID: 38469563 PMC: 10926212. DOI: 10.1016/j.isci.2024.109301.


Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review.

Njei B, Al-Ajlouni Y, Ugwendum D, Abdu M, Forjindam A, Mohamed M Transl Gastroenterol Hepatol. 2024; 9:11.

PMID: 38317742 PMC: 10838615. DOI: 10.21037/tgh-23-31.


Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?.

Mitrovic B, Gluvic Z, Obradovic M, Radunovic M, Rizzo M, Banach M Arch Med Sci. 2023; 19(4):884-894.

PMID: 37560721 PMC: 10408022. DOI: 10.5114/aoms/150639.


References
1.
Chen C, Sun C, Tang D, Yang G, Zhou X, Wang D . Identification of key genes in glioblastoma-associated stromal cells using bioinformatics analysis. Oncol Lett. 2016; 11(6):3999-4007. PMC: 4888085. DOI: 10.3892/ol.2016.4526. View

2.
Ludwig J, Viggiano T, MCGILL D, Oh B . Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980; 55(7):434-8. View

3.
Liang B, Li C, Zhao J . Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Med Oncol. 2016; 33(10):111. DOI: 10.1007/s12032-016-0829-6. View

4.
Angulo P . Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31. DOI: 10.1056/NEJMra011775. View

5.
Ahrens M, Ammerpohl O, von Schonfels W, Kolarova J, Bens S, Itzel T . DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013; 18(2):296-302. DOI: 10.1016/j.cmet.2013.07.004. View